Patient-monitoring Masimo nets CE mark for noninvasive ‘supersensor’

CE mark showing construction lines
The Rainbow Super DCI-mini sensor reduces the need for multiple sensors to measure parameters, such as oxygen saturation and carboxyhemoglobin levels, in the blood.

Masimo has earned a CE mark for a reusable finger sensor that noninvasively measures a range of physiological parameters at the same time. This reduces the need to use multiple sensors in patient monitoring.

The reusable Rainbow Super DCI-mini sensor may be used to spot-check patients weighing 3 kg or more. It can be applied to an adult’s or child’s finger, and to an infant’s finger, thumb or great toe.

In addition to measuring oxygen saturation (SpO2), it also measures total hemoblogin (SpHb), carboxyhemoglobin (SpCO), methemoglobin (SpMet), and arterial oxygen saturation (SpO2), the company said.


Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

RELATED: Mindray Medical shells out $25M to settle pulse oximeter patent battle with Masimo

Monitoring carboxyhemoglobin can help healthcare staff identify heightened carbon monoxide levels that may otherwise be missed in frontline settings, such as emergency care, the company said. Watching a patient’s methemoglobin—a form of hemoglobin that cannot bind oxygen—is useful in settings, such as the operating room, where drugs are used that can cause methemoglobinemia

“Since the invention of rainbow technology, we have been wanting our customers to be able to measure SpCO, SpMet, SpHb and SpO2 simultaneously. Now they can,” said Masimo CEO Joe Kiani. “In addition, we have been pursuing a spot-check sensor that fits all patients across the age spectrum. We believe the rainbow Super DCI-mini sensor will be especially valuable for use in triage and emergency care situations."


Suggested Articles

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.

Agilent launched a new analyzer for research that observes cell behavior in real time while also collecting biosensor information.

Five years after Congress passed a law to reduce unnecessary MRIs and CT scans, federal officials have yet to implement it.